Skip to content

Clinical trials

Terminated Cardiovascular Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Terminated Country / region: Poland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20091
20101
20111
20122
20132
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Amgen1
AstraZeneca1
Eli Lilly and Company1
Forest Laboratories1
Hoffmann-La Roche1
Ixaka Ltd1
National Institute of Cardiology, Warsaw, Poland1
Sanofi1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases11
Myocardial Infarction4
Heart Diseases3
Stroke3
Diabetes Mellitus, Type 22
Heart Failure2
Hyperlipidemias2
Acute Coronary Syndrome1
Arrhythmias, Cardiac1
Chronic Limb-Threatening Ischemia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.